Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
137,278,139
-
Total 13F shares
-
37,861,777
-
Share change
-
-224,886
-
Total reported value
-
$1,297,519,769
-
Put/Call ratio
-
86%
-
Price per share
-
$34.27
-
Number of holders
-
60
-
Value change
-
-$4,030,120
-
Number of buys
-
42
-
Number of sells
-
15
Institutional Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q1 2020
As of 31 Mar 2020,
Vir Biotechnology, Inc. - Common Stock (VIR) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,861,777 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, Temasek Holdings (Private) Ltd, ICONIQ Capital, LLC, Alphabet Inc., Alaska Permanent Fund Corp, Capital International Investors, BlackRock Inc., EcoR1 Capital, LLC, VANGUARD GROUP INC, and BAILLIE GIFFORD & CO.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.